F.D.A. Approves Alzheimer ’s Drug Despite Fierce Debate Over Whether It Works

Aducanumab, or Aduhelm, is the first new Alzheimer ’s treatment in 18 years and the first to attack the disease process. But some experts say there’s not enough evidence it can address cognitive symptoms.

Source: NYT Health - June 8, 2021 Category: Consumer Health News Authors: Pam Belluck and Rebecca Robbins Tags: Alzheimer ' s Disease Drugs (Pharmaceuticals) Food and Drug Administration Clinical Trials Biogen Inc Source Type: news